BioFlag Unveils Innovative Probiotic Solutions at Vitafoods Europe 2025

BioFlag Showcases Innovative Probiotic Solutions at Vitafoods Europe 2025



BARCELONA, Spain - On May 20, 2025, BioFlag CO., LTD., a leading probiotic company based in China, proudly presented its range of scientifically validated functional probiotics at the highly anticipated Vitafoods Europe 2025 event. This occasion not only showcased their innovative product line but also attracted significant media coverage from around the globe.

The standout offerings from BioFlag included clinically tested probiotic strains along with ready-to-consume probiotic products designed for various health benefits such as gut health, immune regulation, metabolic wellness, weight management, oral care, and emotional well-being. Moreover, the company introduced customized probiotic solutions that meet stringent regulatory standards in both European and American markets.

Among the most remarkable innovations presented were well-researched strains like Bifidobacterium animalis subsp. lactis BL-99. This strain, sourced from BioFlag's proprietary library of mother-child probiotic strains, is protected by twelve Chinese patents related to gut health, immune regulation, and bone health. It's commonly incorporated into infant formulas, yogurts, and dietary supplements.

Another significant strain featured was Lactobacillus paracasei K56, isolated from the intestines of healthy Chinese infants. This strain has undergone clinical trials with proven effectiveness in reducing body fat, visceral fat, and waist circumference, underpinned by nine Chinese patents and supported by twelve published research studies.

Additionally, BioFlag highlighted Bifidobacterium animalis subsp. lactis CP-9, which has been sourced from the breast milk of healthy Chinese mothers. This strain is patented in China for its applications in combating obesity and treating or preventing jaundice.

Serving as a representative of the Chinese probiotic industry, BioFlag showcased its exceptional capabilities across the entire industrial chain, including:
  • - A proprietary library containing over 3,500 strains and more than 30 functional screening platforms.
  • - Over 130 granted patents and more than 100 published scientific papers.
  • - International certifications including GMP, FSSC22000, and HALAL.
  • - Manufacturing capacities for various forms such as powders, tablets, capsules, and more.

During the expo, BioFlag successfully forged cooperation agreements with numerous companies and institutions across Europe, North America, and other regions. A company spokesperson remarked, "With nearly two decades of experience in functional probiotics, we are committed to advancing research and innovation in smart manufacturing to offer superior health solutions to our global customers."

For additional details, you can explore more at BioFlag's official website.

BioFlag Showcases Innovative Probiotic Solutions

As the demand for high-quality probiotics continues to grow, BioFlag's dedication to research and development positions it as a frontrunner in the health and wellness sector, promising consumers access to effective and innovative probiotic solutions for everyday health needs.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.